NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Breast Cancer



Molecular interaction found to trigger particularly aggressive form of disease



February 9th, 2006

Researchers have identified a molecular interaction that triggers a particularly aggressive form of breast cancer and suggest that attacking this target with selective drugs might improve treatment.

In the January 2006 issue of Cancer Cell, a team led by Qunyan Yu, MD, and Piotr Sicinski, MD, PhD, of the Dana-Farber Cancer Institute, report that the interaction of a certain mutated oncogene and the newly described growth control flaw is seen in about 10% of breast cancers - and the deadliest ones (Requirement for CDK4 kinase function in breast cancer. Cancer Cell, January 2006;9(1):23-32).

The cancer results from a cascade of molecular events....


Source: Women's Health Weekly (2006-02-09)

NewsRx Passes
Advertisement
More Articles

------------------------
Security by Verisign PR Login